Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dunne

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 4, 2017
A Phase II Toxicity End Point Trial (ICORG 99-09) of Accelerated Dose-escalated Hypofractionated Radiation in Non-small Cell Lung CancerD N Cagney, P G Thirion, M T Dunne, et al.
British Journal of Cancer|December 9, 2022
Efficacy and toxicity of primary re-irradiation for malignant spinal cord compression based on radiobiological modelling: a phase II clinical trialNeil D Wallace, Mary T Dunne, Orla McArdle, et al.
British Journal of Cancer|March 12, 2020
Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compressionPierre G Thirion, Mary T Dunne, Paul J Kelly, et al.
The Lancet. Oncology|January 20, 2022
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysisAmar U Kishan, Yilun Sun, Holly Hartman, et al.
Science (New York, N.Y.)|May 8, 2010
Climate change and the integrity of scienceP H Gleick, R M Adams, R M Amasino, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 4, 2017
A Phase II Toxicity End Point Trial (ICORG 99-09) of Accelerated Dose-escalated Hypofractionated Radiation in Non-small Cell Lung CancerD N Cagney, P G Thirion, M T Dunne, et al.
British Journal of Cancer|December 9, 2022
Efficacy and toxicity of primary re-irradiation for malignant spinal cord compression based on radiobiological modelling: a phase II clinical trialNeil D Wallace, Mary T Dunne, Orla McArdle, et al.
British Journal of Cancer|March 12, 2020
Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compressionPierre G Thirion, Mary T Dunne, Paul J Kelly, et al.
The Lancet. Oncology|January 20, 2022
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysisAmar U Kishan, Yilun Sun, Holly Hartman, et al.
Science (New York, N.Y.)|May 8, 2010
Climate change and the integrity of scienceP H Gleick, R M Adams, R M Amasino, et al.
Pageof 6